Literature DB >> 18491230

Comorbid anxiety in bipolar disorder alters treatment and prognosis.

Rif S El-Mallakh1, Michael Hollifield.   

Abstract

Mood disorders in general, and bipolar disorder in particular, are unique among the psychiatric conditions in that they are associated with extraordinarily high rates of comorbidity with a multitude of psychiatric and medical conditions. Among all the potential comorbidities, co-occurring anxiety disorders stand out due to their very high prevalence. Outcome in bipolar illness is worse in the presence of a comorbid anxiety disorder. The coexistence of an anxiety disorder presents a particularly difficult challenge in the treatment of bipolar illness since antidepressants, the mainstay of pharmacologic treatments for anxiety, may adversely alter the course of manic-depression. Identification of anxiety disorders in bipolar patients is important. The treatment plan needs to balance the potential benefit and harm of antidepressant administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18491230     DOI: 10.1007/s11126-008-9071-5

Source DB:  PubMed          Journal:  Psychiatr Q        ISSN: 0033-2720


  108 in total

1.  Rapid cyclers, temperament, and antidepressants.

Authors:  A Kukopulos; B Caliari; A Tundo; G Minnai; G Floris; D Reginaldi; L Tondo
Journal:  Compr Psychiatry       Date:  1983 May-Jun       Impact factor: 3.735

Review 2.  Comorbidity of bipolar and eating disorders: distinct or related disorders with shared dysregulations?

Authors:  Susan L McElroy; Renu Kotwal; Paul E Keck; Hagop S Akiskal
Journal:  J Affect Disord       Date:  2005-06       Impact factor: 4.839

3.  Anxiety disorder comobidity in Bipolar I Disorder: relationship to depression severity and treatment outcome.

Authors:  Brandon A Gaudiano; Ivan W Miller
Journal:  Depress Anxiety       Date:  2005       Impact factor: 6.505

Review 4.  Prevalence and impact of comorbid anxiety and bipolar disorder.

Authors:  Martin B Keller
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

5.  The efficacy of selective serotonin reuptake inhibitors in adult social anxiety disorder: a meta-analysis of double-blind, placebo-controlled trials.

Authors:  Dawson W Hedges; Bruce L Brown; David A Shwalb; Kirk Godfrey; A Manja Larcher
Journal:  J Psychopharmacol       Date:  2006-05-19       Impact factor: 4.153

Review 6.  Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety.

Authors:  Steven D Hollon; Michael O Stewart; Daniel Strunk
Journal:  Annu Rev Psychol       Date:  2006       Impact factor: 24.137

7.  The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis.

Authors:  M Tohen; S M Strakowski; C Zarate; J Hennen; A L Stoll; T Suppes; G L Faedda; B M Cohen; P Gebre-Medhin; R J Baldessarini
Journal:  Biol Psychiatry       Date:  2000-09-15       Impact factor: 13.382

8.  Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial.

Authors:  P Tucker; R Zaninelli; R Yehuda; L Ruggiero; K Dillingham; C D Pitts
Journal:  J Clin Psychiatry       Date:  2001-11       Impact factor: 4.384

Review 9.  The integration of pharmacological therapy for comorbid psychiatric and addictive disorders.

Authors:  N S Miller; J C Guttman
Journal:  J Psychoactive Drugs       Date:  1997 Jul-Sep

10.  A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

Authors:  Mark Pollack; Richard Mangano; Richard Entsuah; Evan Tzanis; Naomi M Simon; Ying Zhang
Journal:  Psychopharmacology (Berl)       Date:  2007-06-23       Impact factor: 4.530

View more
  16 in total

1.  An epidemiologic and clinical overview of medical and psychopathological comorbidities in major psychoses.

Authors:  A Carlo Altamura; Marta Serati; Alessandra Albano; Riccardo A Paoli; Ira D Glick; Bernardo Dell'Osso
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2011-02-18       Impact factor: 5.270

2.  A single infusion of ketamine improves depression scores in patients with anxious bipolar depression.

Authors:  Dawn F Ionescu; David A Luckenbaugh; Mark J Niciu; Erica M Richards; Carlos A Zarate
Journal:  Bipolar Disord       Date:  2014-11-14       Impact factor: 6.744

3.  A factor analysis of different temperament domains in a border region in rural Southern California.

Authors:  Alvaro Camacho; Alan N Simmons; Bernardo Ng; Scott C Matthews; Hagop S Akiskal
Journal:  J Affect Disord       Date:  2010-04-13       Impact factor: 4.839

4.  Transdiagnostic treatment of bipolar disorder and comorbid anxiety with the unified protocol: a clinical replication series.

Authors:  Kristen K Ellard; Thilo Deckersbach; Louisa G Sylvia; Andrew A Nierenberg; David H Barlow
Journal:  Behav Modif       Date:  2012-07-19

5.  The clinical management of bipolar disorder: a review of evidence-based guidelines.

Authors:  Kevin R Connolly; Michael E Thase
Journal:  Prim Care Companion CNS Disord       Date:  2011

6.  Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial.

Authors:  Kristen K Ellard; Emily E Bernstein; Casey Hearing; Ji Hyun Baek; Louisa G Sylvia; Andrew A Nierenberg; David H Barlow; Thilo Deckersbach
Journal:  J Affect Disord       Date:  2017-05-10       Impact factor: 4.839

7.  Heart rate variability in bipolar mania and schizophrenia.

Authors:  Brook L Henry; Arpi Minassian; Martin P Paulus; Mark A Geyer; William Perry
Journal:  J Psychiatr Res       Date:  2009-08-22       Impact factor: 4.791

8.  Functional outcome in bipolar disorder: the big picture.

Authors:  Boaz Levy; Emily Manove
Journal:  Depress Res Treat       Date:  2011-09-27

9.  Obsessive-compulsive disorder comorbidity: clinical assessment and therapeutic implications.

Authors:  Stefano Pallanti; Giacomo Grassi; Elisa Dinah Sarrecchia; Andrea Cantisani; Matteo Pellegrini
Journal:  Front Psychiatry       Date:  2011-12-21       Impact factor: 4.157

10.  Obsessive-compulsive disorder and related disorders: a comprehensive survey.

Authors:  Michele Fornaro; Filippo Gabrielli; Claudio Albano; Stefania Fornaro; Salvatore Rizzato; Chiara Mattei; Paola Solano; Valentina Vinciguerra; Pantaleo Fornaro
Journal:  Ann Gen Psychiatry       Date:  2009-05-18       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.